You are here

FLI1 Expression in Breast Cancer Cell Lines and Primary Breast Carcinomas is Correlated with ER, PR and HER2

Journal Name:

Publication Year:

Author Name
Abstract (2. Language): 
FLI1 is a member of ETS family of transcription factors that regulate a variety of normal biologic activities including cell proliferation, differentiation, and apoptosis. The expression of FLI1 and its correlation with well-known breast cancer prognostic markers (ER, PR and HER2) was determined in primary breast tumors as well as four breast cancer lines including: MCF-7, T47D, MDA-MB-231 and MDA-MB-468 using RT-qPCR with either 18S rRNA or ACTB (β-actin) for normalization of data. FLI1 mRNA level was decreased in the breast cancer cell lines under study compared to the normal breast tissue; however, Jurkat cells, which were used as a positive control, showed overexpression compared to the normal breast. Regarding primary breast carcinomas, FLI1 is significantly under expressed in all of the stages of breast cancer upon using 18S as an internal control. This FLI1 expression was correlated with ER, PR and HER2 status. In conclusion FLI1 can be exploited as a preliminary marker that can predict the status of ER, PR and HER2 in primary breast tumors.
87
95

REFERENCES

References: 

[1] Sharrocks, Andrew D. “The ETS-domain transcription factor family.” Nature Reviews Molecular Cell
Biology Vol. 2, No. 11, 2001, pp. 827-37.
[2] Graves, Barbara J., and Jeannine M. Petersen. “Specificity within the ETS family of transcription factors.” Advances
in Cancer Research Vol. 75, 1998, pp. 1-57.
[3] Maroulakou, Ioanna G., and Damon B. Bowe. “Expression and function of ETS transcription factors in mammalian
development: a regulatory network.” Oncogene Vol. 19, No. 55, 2000, p. 6432.
[4] Truong, Amandine HL, and Yaacov Ben-David. “The role of Fli-1 in normal cell function and malignant
transformation.” Oncogene Vol. 19, No. 55, 2000, p. 6482.
[5] Watson, Dennis K., et al. “The ERGB/Fli-1 gene: Isolation and characterization of a new member of the family
of human ETS transcription factors.” Cell Growth and Differentiation Vol. 3, 1992, pp. 705-13.
[6] Ben-David, Yaacov, Elizabeth B. Giddens, and Alan Bernstein. “Identification and mapping of a common
proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.” Proceedings of
the National Academy of Sciences Vol. 87, No. 4, 1990, pp. 1332-36.
[7] Ben-David, Y., et al. “Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a
new member of the ETS gene family, Fli-1, closely linked to c-ets-1.” Genes & Development Vol. 5, No. 6, 1991,
pp. 908-18.
Inam Jasim Lafta Int J Med Res Health Sci 2017, 6(12): 87-95
95
[8] Selleri, L., et al. “Cloning of the entire FL11 gene, disrupted by the Ewing’s Sarcoma translocation breakpoint on
11q24, in a yeast artificial chromosome.” Cytogenetic and Genome Research Vol. 67, No. 2, 1994, pp. 129-36.
[9] Delattre, Olivier, et al. “Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in
human tumours.” Nature Vol. 359, No. 6391, 1992, pp. 162-65.
[10] Bonin, Gersende, et al. “Chimeric EWS-FL11 Transcript in a Ewing Cell Line with a Complex t (11; 22; 14)
Translocation.” Cancer Research Vol. 53, No. 16, 1993, pp. 3655-57.
[11] Welford, Scott M., et al. “DNA binding domain-independent pathways are involved in EWS/FLI1-mediated
oncogenesis.” Journal of Biological Chemistry Vol. 276, No. 45, 2001, pp. 41977-84.
[12] Sakurai, Takuya, et al. “Functional roles of Fli-1, a member of the Ets family of transcription factors, in human
breast malignancy.” Cancer Science Vol. 98, No. 11, 2007, pp. 1775-84.
[13] Tamir, Ami, et al. “Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid
proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during
differentiation.” Molecular and Cellular Biology Vol. 19, No. 6, 1999, pp. 4452-64.
[14] Asano, Yoshihide, and Maria Trojanowska. “Fli1 represses transcription of the human α2 (I) collagen gene by
recruitment of the HDAC1/p300 complex.” PloS one Vol. 8, No. 9, 2013, p. e74930.
[15] Truong, Amandine HL, et al. “Direct transcriptional regulation of MDM2 by Fli-1.” Oncogene Vol. 24, No. 6,
2005, pp. 962-969.
[16] Scheiber, Melissa N., et al. “FLI1 expression is correlated with breast cancer cellular growth, migration, and
invasion and altered gene expression.” Neoplasia Vol. 16, No. 10, 2014, pp. 801-13.
[17] He, Jin, et al. “Profile of ETS gene expression in human breast carcinoma.” Cancer Biology & Therapy Vol. 6,
No. 1, 2007, pp. 76-82.
[18] Zhang, Jianjun, et al. “Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene
friend leukemia virus integration 1 gene.” Cancer Vol. 117, No. 1, 2011, pp. 86-95.
[19] Crossen, Peter E., et al. “Identification of amplified genes in a patient with acute myeloid leukemia and double
minute chromosomes.” Cancer genetics and cytogenetics Vol. 113, No. 2, 1999, pp. 126-33.
[20] Tyybäkinoja, Anne, et al. “Amplified, lost, and fused genes in 11q23–25 amplicon in acute myeloid leukemia,
an array-CGH study.” Genes, Chromosomes and Cancer Vol. 45, No. 3, 2006, pp. 257-64.
[21] Savli, Hakan, Sema Sirma, and Uğur Özbek. “Quantification of the FLI1 gene expression by real-time quantitative
RT-PCR.” Turkish Journal of Medical Sciences Vol. 33, No. 1, 2003, pp. 21-25.
[22] Dhulipala, Prasad DK, et al. “Fli-1b is generated by usage of differential splicing and alternative
promoter.” Oncogene Vol. 17, No. 9, 1998.
[23] Holliday, Deborah L., and Valerie Speirs. “Choosing the right cell line for breast cancer research.” Breast Cancer
Research Vol. 13, No. 4, 2011, p. 215.
[24] Kao, Jessica, et al. “Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a
resource for cancer gene discovery.” PloS one Vol. 4, No. 7, 2009, p. e6146.
[25] Hattori, Tomoyasu, et al. “Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts.” Journal of
Investigative Dermatology Vol. 131, No. 7, 2011, pp. 1469-76.

Thank you for copying data from http://www.arastirmax.com